Tyra Biosciences (TYRA) Assets Average (2021 - 2026)

Tyra Biosciences' Assets Average history runs 6 years deep, the most recent figure standing at $347.3 million for Q1 2026.

• Quarterly Assets Average fell 1.75% year-over-year to $347.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $347.3 million (down 1.75% YoY) and the FY2025 annual result came in at $323.1 million, up 9.63% from the prior year.
• Assets Average was $347.3 million for Q1 2026 at Tyra Biosciences, up from $292.2 million in the prior quarter.
• Across five years, Assets Average topped out at $398.6 million in Q2 2024 and bottomed at $232.1 million in Q4 2023.
• A 5-year average of $308.7 million and a median of $302.8 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2024 — Assets Average surged 60.3% — and 2025, when it fell 21.46%.
• Tyra Biosciences' Assets Average stood at $271.1 million in 2022, then retreated by 14.38% to $232.1 million in 2023, then jumped by 60.3% to $372.1 million in 2024, then slipped by 21.46% to $292.2 million in 2025, then advanced by 18.85% to $347.3 million in 2026.
• Business Quant data shows TYRA's Assets Average at $347.3 million in Q1 2026, $292.2 million in Q4 2025, and $311.7 million in Q3 2025.